Market requirements · NL
Netherlands
The IGJ and the NVWA assess offerings jointly and have stated their position on research-use framing directly. Semaglutide remains under supplementary protection in the Netherlands until 2031.
Buyers in this market search for: peptiden groothandel, peptiden kopen groothandel onderzoek.
| Tell us the compounds you need for Netherlands. | Ask about Netherlands |
The regime
How compounds are classified in Netherlands
| Governing law | The Geneesmiddelenwet, assessed alongside the Opiumwet and the Warenwet. The IGJ and the NVWA assess offerings jointly. |
|---|---|
| The regulator's stated position | The IGJ and NVWA have stated publicly that offering medicines without a trading licence is unlawful even where terms such as 'for research purposes' are used. Between November 2025 and February 2026 the two agencies took 43 websites offline, and characterised research-chemical disclaimers on those sites as circumvention rather than as a limitation on use. |
| GLP-1 class | Semaglutide remains under a Dutch Supplementary Protection Certificate until 19 March 2031. The compound patent expired in March 2026, but the SPC is a separate instrument and it holds. On 5 August 2026 the District Court of The Hague granted an injunction against a Dutch compounding pharmacy over an unapproved compounded semaglutide preparation, with recall, disclosure of commercial customers and the API supplier, and penalty payments. |
| Prescription-only compounds | Somatropin and the gonadotropins may only be offered, sold or delivered by a doctor or pharmacist. The IGJ ranks illegal medicine trade as an enforcement priority and has fined wholesalers. |
| Enforcement posture | Active at wholesale level, not only at retail. |
| Already supplying Netherlands? Send the compounds and volumes you buy today and we will quote against them. | Send your list |
Your obligations
What a buyer in Netherlands needs settled
- Hold a Dutch wholesale trading licence if your activity requires one.
- Assume the GLP-1 class is unavailable for Dutch onward supply until the SPC position changes.
- Do not rely on a research-use description as a defence. The Dutch regulator has stated its view of that framing.
- Take Dutch counsel before establishing a Dutch supply route.
We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.
Sources
Check this yourself
Every position above traces to a dated public document. The authority, the document, the date and the link are below.
| Authority and document | Date | Link |
|---|---|---|
| IGJ and NVWA Joint action taking websites offline for harmful substances | 16 April 2026 | www.igj.nl/actueel/nieuws/2026/04/16/igj-en-nvwa-halen-tie... |
| IGJ and CBG Joint warning on illegal online supply of obesity and diabetes medicines | 3 September 2025 | www.igj.nl/actueel/nieuws/2025/09/03/igj-en-cbg-waarschuwe... |
| IGJ Standing guidance on illegal medicines | undated | www.igj.nl/zorgsectoren/geneesmiddelen/illegale-geneesmidd... |
Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.
Market brief
Take the Netherlands brief as a PDF
The regime, the buyer obligations and all 3 sources, dated and linked, in one document you can forward.
Nearby
Benelux and nearby markets
Buyers supplying one of these usually supply the others. The requirements are not the same.
| Code | Market | Sources | |
|---|---|---|---|
| BE | Belgium | 3 sources | Belgium applies EU medicines law through the FAGG, which has published a GLP-1... |
| PL | Poland | 2 sources | GIF and GIS have issued a joint public warning on synthetic peptides offered a... |
| CZ | Czechia | 2 sources | SUKL holds that most synthetic peptides meet the functional definition of a me... |
Scope
How to use this page
A summary of the published regulatory position in Netherlands as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.
It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.
Questions
Supplying into Netherlands
Do you supply into Netherlands?
We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Netherlands depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.
Who carries the compliance obligation?
The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.
How current is this page?
It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.
We already supply into Netherlands. What changes if we source from you?
The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.
Is this legal advice?
No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.
Enquire about supply into Netherlands
Tell us the compounds and your authorisations. We confirm per compound before anything ships.